An observational study in Osteoporosis Fracture, sponsored by Peking University Third Hospital. Recruiting at 1 site in China. Open to participants aged 50 Years to 100 Years. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Peking University Third Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Osteoporotic Fractures with a site in China — 7 open to participants now, 8 under way, none of them phase 3. Osteoporotic Fractures · China.
Among the 13 studies in Osteoporotic Fractures with a site in China, this one is one of 3 that started in 2021, is one of 5 observational ones, and was the 11th registered.
87 studies on the registry are indexed under Osteoporotic Fractures; 22 are open to participants now.
Browse Osteoporotic Fractures studies →7 of the 13 studies in Osteoporotic Fractures with a site in China are open now. Recruiting first, the newest first:
The Seventh Affiliated Hospital of Sun Yat-sen University · Sites in China
Ages 50–90
Peking Union Medical College Hospital · Sites in China
Ages 45–90
He Qifei · Sites in China
Ages 65+
Suzhou Municipal Hospital · Sites in China
Ages 65+ · Healthy volunteers
Jiawei Jiang · Sites in China
Ages 58–84
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 14 Osteoporotic Fractures studies recruiting now, 9 (64%) set no upper age limit and none (0%) stop at 75 or younger; 1 takes children under 18; 2 take healthy volunteers.
This study: 50 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 3 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 500 is above the median of 300 across 36 observational studies indexed under Osteoporotic Fractures.
Median enrollment 321 across the 8 interventional studies, 500 across the 5 observational. Of the 5 that completed or were terminated, 1 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 13 have an industry lead sponsor. The 10 most frequent:
Peking University Third Hospital is the lead sponsor of 752 studies on the registry; 273 are open to participants now.
Peking University Third Hospital has 1 study filed under Osteoporotic Fractures — fewer than ten, so there is no comparison to draw.
3 of the studies in Osteoporotic Fractures with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07165158The First Affiliated Hospital of Xiamen UniversityThe Effect of Semaglutide on Bone Health | 2026-12-31 |
| NCT06379243The Seventh Affiliated Hospital of Sun Yat-sen UniversityDevelopment and Validation of a Postoperative Re-fracture Risk Model for Osteoporotic Spinal Fractures | 2026-12-31 |
| NCT07178327Shanghai TTM-Bio Technology Co., LtdPhase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101 | 2027-03-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 13 studies in Osteoporotic Fractures with a site in China, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Our research group plans to establish a disease specific bidirectional cohort study on prognosis prediction of acute osteoporotic vertebral compression fracture based on imaging and clinical data, and to establish a comprehensive bioinformation database on OVCFs, including patient status, clinical data, laboratory examination, and imaging examination database
All the acute osteoporosis vertebral compression fracture patients who search for treatments in our hospital
Inclusion Criteria: all patients who suffer a acute osteoporosis vertebral compression fractures -
Exclusion Criteria: those who have endocrine disease which have impacts on the bone density
-
Other: no intervention
no intervention
VAS value
the visual analogue scale value of patient
Time frame: 2 weeks, 1 month, 2 months, 3months, 6 months and 12 months
vertebrae height
the height of the vertebrae according to the X rays
Time frame: 2 weeks, 1 month, 2 months, 3months, 6 months and 12 months
T value
the T value of the dual energy X-ray absorptiometry
Time frame: 6months and 12 months
Started Jan 2021 (actual). Primary completion is estimated for Dec 2024, 47 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking University Third Hospital →